Covid-19 variant BA.3.2 Cicada detected in 25 US states under surveillance

The BA.3.2 variant of Covid-19, known as Cicada, has been identified in at least 25 Estados Unidos states and is undergoing strict monitoring by health authorities. The strain presents a high number of mutations in the spike protein, the viral structure responsible for cellular infection. Embora While overall cases of Covid remain at low levels nationally, the strain has gained momentum in several countries since last fall. Especialistas warn that genetic changes can reduce the protection provided by previous infections or vaccination.

Origem and evolution of the Cicada lineage

The BA.3.2 variant emerged in África from Sul in November 2024 as a direct descendant of BA.3, an omicron sublineage that briefly circulated in 2022. Ela evolved inconspicuously for more than a year, overshadowed by other dominant strains such as XFG and NB.1.8.1. Starting in September 2025, detections began to increase in different regions of the world, including Estados Unidos. Virologistas note that this slow trajectory of spread differentiates BA.3.2 from previous variants that spread quickly after emergence.

Características genetics and immune escape potential

BA.3.2 has between 70 and 75 mutations in the spike protein compared to recent variants, making it genetically distinct from the JN.1 lineages that served as the basis for the 2025-2026 vaccines. Essa amount of changes can make the virus appear less familiar to the human immune system. Estudos laboratory studies indicate potential for immune escape, although data on the real impact on populations is still limited.

• The variant presents substitutions and deletions that differentiate its spike protein from others in circulation.
• Algumas mutations reduce binding capacity to human cells, potentially limiting transmission efficiency in certain contexts.
• Saúde’s Organização Mundial added BA.3.2 to the list of variants under monitoring in December 2025.

Especialistas from public health emphasize that the variant has not yet demonstrated a sustained growth advantage over current dominant strains. Authorities continue to carry out genomic surveillance to assess possible future developments and changes in the spread pattern.

Disseminação on Estados Unidos and global presence

The first detection of BA.3.2 in Estados Unidos occurred in June 2025, in a traveler returning from Holanda via Aeroporto Internacional of São Francisco. Desde then positive samples appeared in international travelers, patients with symptoms, and wastewater analyses. Até February 2026, the strain had been identified in 132 sewage samples from 25 different states. Nos Estados Unidos prevalence remains low, with approximately 0.19% of national genomic sequences in the initial monitoring period, although more recent data indicates presence in 3.7% of wastewater samples nationwide.

The variant also circulates in at least 23 countries. In nations such as Dinamarca, Alemanha and Holanda, it accounted for around 30% of the sequences analyzed between November 2025 and January 2026. BA.3.2 did not overcome predominant variants such as XFG and its descendants, suggesting that it circulates coexistingly with other lineages without causing a significant increase in the total number of cases.

Sintomas and clinical picture of the infection

The symptoms reported in BA.3.2 cases follow the pattern observed in other Covid-19 variants in circulation. The most common signs include cough, fever or chills, sore throat and nasal congestion. Outros common symptoms involve shortness of breath, fatigue, headache and changes in smell or taste. Alguns individuals report gastrointestinal discomforts such as nausea, vomiting, or diarrhea. Esses symptoms usually disappear within a few days with rest and adequate hydration.

Leia Tambem

Park Mi-sun returns to TV after battle with breast cancer

Hiroshima Carp confirm Tokoda against Nippon Ham on the 3rd after game postponed by rain

Older, poorly maintained vehicles face problems when using E10 gasoline

Não there is evidence of increased disease severity or hospitalization rates associated specifically with this variant. The strain remains sensitive to the antivirals available for the treatment of Covid-19, and the clinical picture is not significantly different from infections caused by other omicron lineages in circulation.

Proteção vaccination and preventive measures

Vaccines against Covid-19 formulated for the JN.1 lineage offer protection against severe forms of the disease even in the face of variants such as BA.3.2. Estudos laboratory tests show reduced neutralization of antibodies against this new strain, but observational data is still limited. Current formulations continue to reduce the risk of serious complications in vulnerable groups. Pessoas over the age of 65 or with pre-existing conditions that compromise the immune system should keep their vaccination schedule up to date and talk to their doctors about the need for booster doses when the interval since the last injection exceeds six to twelve months.

Simple Medidas remains effective in limiting transmission. Testar If symptoms appear, staying at home when sick and wearing masks in closed or crowded environments reduces the risk of contagion. Hand hygiene and ventilation of indoor spaces also contribute to controlling spread in communities. Maintaining healthy habits, such as a balanced diet and regular physical activity, supports the proper functioning of the immune system.

Continued Vigilância and Future Prospects

Public health Autoridades utilize multiple surveillance strategies, including genomic sequencing of clinical samples, traveler monitoring, and wastewater analysis. The presence of the variant in sewage samples indicates wider circulation than the number of confirmed cases suggests. Programas like WastewaterSCAN record consistent detections across multiple locations, offering early clues about transmission trends in areas where clinical testing is less frequent.

Especialistas highlight that Covid-19 follows a pattern of constant evolution, with the periodic emergence of new variants. BA.3.2 represents a genetically distinct lineage that deserves attention, although it has not caused significant waves to date. Laboratory and epidemiological monitoring continues to assess any changes in the behavior of the virus and allow for timely adjustments to preventive recommendations.